日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Plasma Protein Biomarkers in Advanced or Metastatic Colorectal Cancer Patients Receiving Chemotherapy With Bevacizumab or Cetuximab: Results from CALGB 80405 (Alliance)

接受贝伐单抗或西妥昔单抗化疗的晚期或转移性结直肠癌患者的血浆蛋白生物标志物:CALGB 80405(联盟)研究结果

Nixon, Andrew B; Sibley, Alexander B; Liu, Yingmiao; Hatch, Ace J; Jiang, Chen; Mulkey, Flora; Starr, Mark D; Brady, John C; Niedzwiecki, Donna; Venook, Alan P; Baez-Diaz, Luis; Lenz, Heinz-Josef; O'Neil, Bert H; Innocenti, Federico; Meyerhardt, Jeffrey A; O'Reilly, Eileen M; Owzar, Kouros; Hurwitz, Herbert I

Interrelationships between Cellular Density, Mosaic Patterning, and Dendritic Coverage of VGluT3 Amacrine Cells

VGluT3 无长突细胞的细胞密度、马赛克图案和树突覆盖之间的相互关系

Patrick W Keeley, Mikayla C Lebo, Jordan D Vieler, Jason J Kim, Ace J St John, Benjamin E Reese

Cabozantinib and Panitumumab for RAS Wild-Type Metastatic Colorectal Cancer

卡博替尼联合帕尼单抗治疗 RAS 野生型转移性结直肠癌

Strickler, John H; Rushing, Christel N; Uronis, Hope E; Morse, Michael A; Niedzwiecki, Donna; Blobe, Gerard C; Moyer, Ashley N; Bolch, Emily; Webb, Renee; Haley, Sherri; Hatch, Ace J; Altomare, Ivy P; Sherrill, Gary B; Chang, David Z; Wells, James L; Hsu, S David; Jia, Jingquan; Zafar, S Yousuf; Nixon, Andrew B; Hurwitz, Herbert I

RasGRP1 is a potential biomarker to stratify anti-EGFR therapy response in colorectal cancer

RasGRP1 是分层结直肠癌抗 EGFR 治疗反应的潜在生物标志物

Oghenekevwe M Gbenedio, Caroline Bonnans, Delphine Grun, Chih-Yang Wang, Ace J Hatch, Michelle R Mahoney, David Barras, Mary Matli, Yi Miao, K Christopher Garcia, Sabine Tejpar, Mauro Delorenzi, Alan P Venook, Andrew B Nixon, Robert S Warren, Jeroen P Roose, Philippe Depeille

Dynamic Changes in Circulating Tumor DNA During Chemoradiation for Locally Advanced Lung Cancer

局部晚期肺癌放化疗期间循环肿瘤DNA的动态变化

Corradetti, Michael N; Torok, Jordan A; Hatch, Ace J; Xanthopoulos, Eric P; Lafata, Kyle; Jacobs, Corbin; Rushing, Christel; Calaway, John; Jones, Greg; Kelsey, Chris R; Nixon, Andrew B

An initial genetic analysis of gemcitabine-induced high-grade neutropenia in pancreatic cancer patients in CALGB 80303 (Alliance)

CALGB 80303(联盟)中吉西他滨诱导胰腺癌患者高级别中性粒细胞减少症的初步基因分析

Innocenti, Federico; Jiang, Chen; Sibley, Alexander B; Denning, Stefanie; Etheridge, Amy S; Watson, Dorothy; Niedzwiecki, Donna; Hatch, Ace J; Hurwitz, Herbert I; Nixon, Andrew B; Furukawa, Yoichi; Kubo, Michiaki; Crona, Daniel J; Kindler, Hedy L; McLeod, Howard L; Ratain, Mark J; Owzar, Kouros

Association of Tumor HER3 Messenger RNA Expression With Panitumumab Efficacy in Advanced Colorectal Cancer

肿瘤HER3信使RNA表达与帕尼单抗治疗晚期结直肠癌疗效的相关性

Seligmann, Jenny F; Hatch, Ace J; Richman, Susan D; Elliott, Faye; Jacobs, Bart; Brown, Sarah; Hurwitz, Herbert; Barrett, Jennifer H; Quirke, Philip; Nixon, Andrew B; Seymour, Matthew T

A Phase I Trial of the IGF-1R Antibody Ganitumab (AMG 479) in Combination with Everolimus (RAD001) and Panitumumab in Patients with Advanced Cancer

IGF-1R 抗体 Ganitumab (AMG 479) 联合依维莫司 (RAD001) 和帕尼单抗治疗晚期癌症患者的 I 期临床试验

Vlahovic, Gordana; Meadows, Kellen L; Hatch, Ace J; Jia, Jingquan; Nixon, Andrew B; Uronis, Hope E; Morse, Michael A; Selim, M Angelica; Crawford, Jeffrey; Riedel, Richard F; Zafar, S Yousuf; Howard, Leigh A; O'Neill, Margot; Meadows, Jennifer J; Haley, Sherri T; Arrowood, Christy C; Rushing, Christel; Pang, Herbert; Hurwitz, Herbert I

Genetic variation determines VEGF-A plasma levels in cancer patients

基因变异决定癌症患者血浆中 VEGF-A 的水平

Innocenti, Federico; Jiang, Chen; Sibley, Alexander B; Etheridge, Amy S; Hatch, Ace J; Denning, Stefanie; Niedzwiecki, Donna; Shterev, Ivo D; Lin, Jiaxing; Furukawa, Yoichi; Kubo, Michiaki; Kindler, Hedy L; Auman, J Todd; Venook, Alan P; Hurwitz, Herbert I; McLeod, Howard L; Ratain, Mark J; Gordan, Raluca; Nixon, Andrew B; Owzar, Kouros

Inositol phosphate multikinase dependent transcriptional control

肌醇磷酸多激酶依赖性转录调控

Hatch, Ace J; Odom, Audrey R; York, John D